Other adverse events clinical criteria · patients with Shigella dysentery
It is very uncertain whether fluoroquinolones changes other adverse events clinical criteria compared with macrolides (very low certainty).
1 finding from 1 review
Diarrhoea · patients with Shigella dysentery
It is very uncertain whether cotrimoxazole changes diarrhoea on compared with beta‐lactams (very low certainty).
1 finding from 1 review
Relapse ‐ not reported · patients with Shigella dysentery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events ‐ not reported · patients with Shigella dysentery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Other adverse events clinical criteria · patients with Shigella dysentery
It is very uncertain whether cotrimoxazole changes other adverse events clinical criteria compared with beta‐lactams (very low certainty).
1 finding from 1 review
Diarrhoea · patients with Shigella dysentery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Relapse ‐ not reported · patients with Shigella dysentery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events ‐ not reported · patients with Shigella dysentery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Other adverse events clinical criteria · patients with Shigella dysentery
It is very uncertain whether cotrimoxazole changes other adverse events clinical criteria compared with fluoroquinolones (norfloxacin) (very low certainty).
1 finding from 1 review
Diarrhoea · patients with Shigella dysentery
It is very uncertain whether cotrimoxazole changes diarrhoea on compared with furazolidone (very low certainty).
1 finding from 1 review
Relapse ‐ not reported · patients with Shigella dysentery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events · patients with Shigella dysentery
Cotrimoxazole led to lower serious adverse events compared with furazolidone; GRADE not reported.
1 finding from 1 review
Other adverse events ‐ not reported · patients with Shigella dysentery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Diarrhoea · patients with Shigella dysentery
It is very uncertain whether oral gentamicin changes diarrhoea at compared with nalidixic acid (very low certainty).
1 finding from 1 review
Relapse ‐ not reported · patients with Shigella dysentery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events ‐ not reported · patients with Shigella dysentery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Other adverse events ‐ not reported · patients with Shigella dysentery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Diarrhoea · patients with Shigella dysentery
It is very uncertain whether sulphonamides changes diarrhoea at compared with tetracycline (very low certainty).
1 finding from 1 review
Relapse ‐ not reported · patients with Shigella dysentery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events ‐ not reported · patients with Shigella dysentery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found